Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Metformin Is Most Effective Diabetes Drug At Reducing BMI – AHRQ Report

Executive Summary

Metformin is more effective than thiazolidinediones and second generation sulfonylureas in decreasing weight and body mass index in type 2 diabetes patients, according to an Agency for Healthcare Research & Quality 1draft report

You may also be interested in...



Do Avandia Benefits Outweigh Risks? AHRQ, Consumer Reports Are Skeptical

An Agency for Healthcare Research & Quality report concluding thiazolidinediones are no more efficacious than metformin could put formulary pressure on the two marketed products in the class -GlaxoSmithKline's Avandia (rosiglitazone) and Lilly/Takeda's Actos (pioglitazone)

Do Avandia Benefits Outweigh Risks? AHRQ, Consumer Reports Are Skeptical

An Agency for Healthcare Research & Quality report concluding thiazolidinediones are no more efficacious than metformin could put formulary pressure on the two marketed products in the class -GlaxoSmithKline's Avandia (rosiglitazone) and Lilly/Takeda's Actos (pioglitazone)

GSK Pushing For ADOPTion Of Avandia For First-Line Type 2 Diabetes Therapy

GlaxoSmithKline plans to use the results of its ADOPT study to establish its thiazolidinedioneAvandia as the standard first-line treatment for type 2 diabetes

Related Content

UsernamePublicRestriction

Register

PS047477

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel